52 algorithm-development-"Multiple"-"Prof"-"Prof"-"Simons-Foundation"-"St" Fellowship positions at UNIVERSITY OF SOUTHAMPTON
Sort by
Refine Your Search
-
high-quality laboratory research to develop and test novel diagnostic methods for heavy menstrual bleeding. They will work closely with clinicians, research nurses, and study participants to integrate
-
opportunity for the successful candidate to develop their career in this exciting area in collaboration with some of the leading experts in the UK. The programme seeks to develop mathematical foundations of AI
-
inspection, develop a database of raw and processed thermographic images of different defects - geometries on composites, test of thermographic image processing tools and techniques (all applicable
-
”, funded by National Grid Electricity Transmission (NGET). This project aims to revolutionise noise mitigation for high-voltage power transformers by developing acoustic metamaterials-based treatments made
-
to cutting-edge international research with real potential to transform diagnosis and care in women’s health. The post holder will undertake high-quality laboratory research to develop and test novel
-
for high-voltage power transformers by developing acoustic metamaterials-based treatments made from sustainable and durable materials that can be retrofitted to existing transformer enclosures. Transformer
-
you will need to evaluate all active thermography approaches for composites inspection, develop a database of raw and processed thermographic images of different defects - geometries on composites, test
-
of railway infrastructure, particularly overhead line equipment structures and installations. This is for a two-year contract until 30/09/2027 to develop and carry out field trials; survey remote sites
-
of Southampton. We are seeking a collaborative and motivated postdoctoral scientist to work on our Blood Cancer UK-funded programme developing next-generation, off-the-shelf immunotherapies for acute myeloid
-
-funded programme developing next-generation, off-the-shelf immunotherapies for acute myeloid leukaemia (AML). This three-year project will harness cytotoxic invariant Natural Killer T (iNKT) cells